PlainRecalls
FDA Drug Critical Class I Terminated

Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial; Diluent for Glucagon, 1 mL syringe. Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285; Glucagon, NDC: 0002-8031-01

Reported: October 20, 2021 Initiated: September 24, 2021 #D-0009-2022

Product Description

Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial; Diluent for Glucagon, 1 mL syringe. Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285; Glucagon, NDC: 0002-8031-01

Reason for Recall

SUBPOTENT DRUG: Vial contained a liquid substance, instead of the expected powder substance. There was also a lack of full drug effect upon administration.

Details

Recalling Firm
Eli Lilly & Company
Units Affected
19,174 syringes
Distribution
Nationwide with the USA and Puerto Rico; Canada, Argentina, Costa Rica, Mexico
Location
Indianapolis, IN

Frequently Asked Questions

What product was recalled?
Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial; Diluent for Glucagon, 1 mL syringe. Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285; Glucagon, NDC: 0002-8031-01. Recalled by Eli Lilly & Company. Units affected: 19,174 syringes.
Why was this product recalled?
SUBPOTENT DRUG: Vial contained a liquid substance, instead of the expected powder substance. There was also a lack of full drug effect upon administration.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 20, 2021. Severity: Critical. Recall number: D-0009-2022.